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Background: Deep Vein Thrombosis (DVT) is an important cause of morbidity and is the first cause of maternal
death after delivery in Western Nations. The risk of venous thromboembolism is present throughout the pregnancy
and is maximal during postpartum, especially after twin delivery. Many of the signs and symptoms of DVT overlap
those of a normal pregnancy causing difficulty for diagnosis.
Case report: We report the case of a 33 year-old woman transferred to our Department one week after caesarean
section for twin delivery. She presented with severe abdominal pain, fever, abdominal distension and shortness of
breath. She had no personal or family history of thromboembolism. Computerized Tomography Scan revealed right
ovarian vein thrombosis, left renal vein thrombosis extending up to the Inferior Vena Cava and pulmonary
embolism with bilateral pleural effusion. Caval filter was positioned and anticoagulation therapy associated with
antibiotics was instituted. Pancreatitis showed up two days after and was promptly treated. Three months after
discharge the caval filter was removed and oral anticoagulation was stopped. During a 12-months follow-up, she
remained stable and symptom free.
Results: Ovarian vein thrombosis is rare but recognition of signs and symptoms is fundamental to start adequate
therapy and avoid potential serious sequelae. The risk for maternal postpartum ovarian vein thrombosis is increased
by caesarean section delivery of twins. Such patients should be closely monitored. We illustrated how an
underestimated condition can lead to massive complications.
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During the third trimester and especially in the first two
weeks following delivery the risk of Venous Thrombo-
embolism (VTE) increases in women and it is the
leading cause of maternal death in Western Countries
[1,2]. VTE risk is five times greater during the
postpartum period than during pregnancy [3] and
postpartum ovarian vein thrombosis (POVT) is an un-
common complication in pregnancy with a prevalence of
0.15-0.18% [4].* Correspondence: lesliefiengo@hotmail.com
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reproduction in any medium, provided the orPOVT is the result of bacterial infections, hyper-
coagulability and reduced blood flow in dilated ovarian
veins [5,6]. Eighty to 90% occur in the right side due to
the dextrotorsion of enlarging uterus with compression
of right ovarian vein.
Symptoms include fever, abdominal pain, nausea,
vomiting. Complications of POVT are rare [5,7] and can
involve renal vein, Inferior Vena Cava (IVC) and lead to
pulmonary embolism (PE) which is a life-threatening
condition and has been reported in 13.2% of patients
with POVT [8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 33-year-old woman gave birth to twins in March 2011
with caesarean section delivery. She was at her second
pregnancy and had no family history of VTE or obesity.
The delivery occurred without complication, with an
Apgar score for each baby of 10. Two days later, the pa-
tient presented symptoms of high fever (up to 42°C)
with chills. Her blood pressure was 90/50 mmHg and
her pulse was 110 b.p.m.. Clinical examination revealed
right lower quadrant pain with rebound tenderness. The
patient stated that at 22 week of pregnancy, she referred
to her doctor right lower abdominal pain but no further
investigations were performed at that time. Since there
was no possibility to perform a colour Doppler ultra-
sound or an ultrasound examination of the Abdomen,
she was transferred one week later in our Department
with the only laboratory data at hand being: hemoglobin
8 g/dL (range 12–15 g/dL); lipase 128 UI/L (range 13–60);
amylase 183 UI/L range (20–100); platelets 150,000
((150–450) x 109/L); PT 5.06 (0,8-1,2); PTT ratio 2.21
(0,8-1,2); fibrinogen 866 mg/dL (200–400); AT III 81%
(80–120); D-Dimer 3376 μg/L (range 0–550).
Computed Tomography (CT) of the abdomen revealed
right ovarian vein thrombosis (ROVT) with a diameter
of 28 mm and thrombosed left renal vein (LRV) with a
maximal diameter of 18 mm, therefore the patient was
treated with intravenous Heparin for 5 days (25.000UI/
24 at 20 mL/h) and antibiotics. Six days after she
complained difficulty of breath and thoracic pain. CT-
scan of the thorax revealed PE with bilateral pleural effu-
sion, diffuse pelvic varicosity with complete ROVT
(diameter of 44 mm) extending to the IVC for 3 cm
leading to an almost complete obstruction right up to
under the renal veins with partial obstruction of the
Iliac bifurcation and External Iliac Vein bilaterallyFigure 1 Abdominal Computed Tomography showing complete
thrombosis of Inferior Vena Cava.
Figure 2 CT-scan showing complete thrombosis of IVC, right
ovarian vein and pelvic varicosity.(Figure 1 and 2). Caval filter (ALN) was placed under local
anaesthesia below the renal veins with a right jugular
puncture.
Anticardiolipin, antiphospholipid antibodies, Protein C
and S, antithrombin III (100;range 80–120), Factor V
Leiden were assessed to rule out congenital thrombophilia.
Intravenous heparin was suspended and low molecular
weight heparin (ClexaneW) was started. Since the patient
referred abdominal pain in the upper left quadrant
irradiated to the back, laboratory tests were performed
showing amylase 182 UI/L (range 20–100) and lipase 204
(range 13–60) as initial pancreatitis. Abdominal ultrasound
demonstrated the presence of gallbladder stones, one of
the multiple cause of pancreatitis in pregnant women. For
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(TPN) and standard medical treatment. After one month
the patient fully recovered and was discharged with anti-
coagulant treatment (CoumadinW, maintaining an INR be-
tween 2.0 and 3.0). Caval filter was removed three months
later, after a control CT-scan that showed the reduction of
the ROVT, LRV and IVC thrombus. The patient is stable
and symptom free at present.
Discussion
VTE remains the most common cause of direct maternal
deaths [9]. POVT can occur after delivery causing severe
complications. In pregnancy there is a progressive alter-
ation in the balance between prothrombotic and anti-
coagulant factors, which both increase fibrin deposition
and reduce fibrinolysis, resulting in a procoagulant state
[10]. Moreover, flow velocity in the lower limbs is
reduced by approximately 50% by the third trimester
[11] and 50% of cases of VTE in pregnancy are
associated with inherited or acquired thrombophilia
[12]. In ninety percent of the cases, the right ovarian
vein is involved due to the incompetence of the valves
[12]. Enlarged pregnant uterus in twins may cause ob-
struction of IVC leading to vein stasis [13] and its
complications. Salomon and Dutizky [5,7] wrote the first
report of an association with twin delivery and the risk
of POVT. The Author concluded that the size of the
uterus during twin pregnancy resulted in compression of
the ovarian vein. However all of their patients affected
underwent artificial reproductive techniques in order to
become pregnant, which was not the case of our patient.
The most important risk factors are multiparity, puer-
perium, post-operative periods, infections, neoplasm,
systemic lupus erythematosus and hypercoagulability
states [1]. Typical presentations include abdominal pain,
pelvic or buttock pain in iliac DVT and neck pain when
associated with Internal Jugular Vein thrombosis. Clin-
ical presentation includes fever and pain to the right iliac
fossa. Differential diagnostic with appendicitis, sepsis,
ovarian torsion is mandatory and must be done in early
stages to avoid massive thrombosis and PE, which can
be fatal in some cases. Unusual presentation includes
Budd-Chiari syndrome and cerebral vein thrombosis
(CVT). In the study of Salomon and Dulitzky, only in
23% of the cases thrombophilia was discerned. Salomon
et al [5]. concluded that the risk for maternal POVT is
increased by caesarean delivery of twins.
Early diagnosis may be done with compression ultra-
sonography (CUS) that has a sensitivity of 97-100% and
a specificity of 98-99% [14], while contrast-enhanced CT
and Magnetic Resonance Imaging (MRI) may confirm
the diagnosis and quantify thrombosis extension and PE
which occurs in 13% of cases [15]. A thick-walled,
enlarged ovarian vein with rim enhancement and centralhypodensity are considered the main CT findings in
POVT [16]. If abdominal pain is present ultrasounds
should be routinely performed during pregnancy to ex-
clude ovarian thrombosis. Recent studies suggested that
the risk of POVT increase after caesarean section [1].
Broad-spectrum antibiotic treatment should be settled
immediately, as should intravenous heparin or low mo-
lecular weight heparin (LMWH); once thrombolysis has
begun, oral anticoagulants must be introduced and
continued for 3 to 6 months. Despite the use of LMWH,
DVT and embolism may develop [17]. The optimum
length of time for maintaining anticoagulation in these
patients is unknown (5), therefore we may consider the
possibility to continue therapy at least for 3 months with
laboratory control.
Caval filter is recommended in extensive DVT and
whenever discontinuation of anticoagulation might carry
high risk of PE [4]. Placement of VCF are particularly
considered in case of a high bleeding risk, or other
contraindications, precluding the use of therapeutic
doses of Anticoagulation [1,4]. There are no studies
regarding the use of graduated elastic compression
stockings (GCS) in pregnant women. However it is likely
that stockings could be beneficial in this scenario [18]. A
meta-analysis in non-pregnant patients showed a reduction
in risk of Post-thrombotic syndrome (PTS) and severe PTS
in patients using GCS after diagnosis of thrombosis.
Hence the recommendation from the Royal College of
Obstetricians and Gynaecologists is that GCS (knee-
length with compression strength of 30–40 mm Hg)
should be applied to help prevent PTS [18].
This leads to the recommendation that all women
should be assessed for the risk factors of VTE in early
pregnancy and that the assessment should be repeated if
the woman is admitted to hospital or develops intercur-
rent problems. The assessment should be repeated any-
way intrapartum or immediately postpartum [18].
In our reported case the complications were not
prevented since the diagnosis and the therapy were
performed too late. Maybe complications could have
been avoided if early ultrasound was performed during
pregnancy as soon as the patient was complaining of
groin pain with no relief.
A better recognition of POVT syndromes leads to earl-
ier diagnosis and more favorable clinical outcomes.
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